A UCSF-led team has discovered at least one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia.
August 16, 2010
August 12, 2010
A mutation found in a mouse gene that also appears in humans might provide new insights into the genetic roots of alcoholism, according to a study led by researchers at the Ernest Gallo Clinic and Research Center and UCSF. The study appears in the August 12, 2010, edition of “PLoS Genetics.”
July 14, 2010
A commercial brain fitness program has been shown to improve memory in older adults, at least in the period soon after training. The findings are the first to show that practicing simple visual tasks can improve the accuracy of short-term, or “working” visual memory.
May 25, 2010
Diana Farmer, the world's first female fetal surgeon, shares her story from her early years as a self-described science geek to her current role as an advocate for high-quality patient care.
May 21, 2010
The cancer vaccine sipuleucel-T -- now commercially branded as Provenge -- will soon be available at a select group of medical centers nationwide, including UCSF.
May 03, 2010
To fight the “diseases of civilization,” a Paleolithic diet filled with fruits, vegetables, leafy greens, nuts, fish and lean meat shows early promise -- but imagine no grains, beans or dairy products.
April 21, 2010
Kevin Barrows, MD, has been appointed as director of Clinical Programs for the UCSF Osher Center for Integrative Medicine.
April 15, 2010
UCSF Chancellor Sue Desmond-Hellmann recently urged stem cell researchers to focus on the primary goal – making new treatments broadly available to benefit patients.
April 07, 2010
An international study published in the March 25 New England Journal of Medicine showed what researchers call a clinical breakthrough in one of the greatest unmet needs for patients with advanced liver disease.
March 18, 2010
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.